AU3902600A - Compositions and methods for the treatment of immune related diseases - Google Patents
Compositions and methods for the treatment of immune related diseasesInfo
- Publication number
- AU3902600A AU3902600A AU39026/00A AU3902600A AU3902600A AU 3902600 A AU3902600 A AU 3902600A AU 39026/00 A AU39026/00 A AU 39026/00A AU 3902600 A AU3902600 A AU 3902600A AU 3902600 A AU3902600 A AU 3902600A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- treatment
- methods
- related diseases
- immune related
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
WOUS99/21547 | 1999-09-15 | ||
PCT/US1999/021547 WO2000015797A2 (en) | 1998-09-17 | 1999-09-15 | Compositions and methods for the treatment of immune related diseases |
PCT/US2000/007377 WO2001019991A1 (en) | 1999-09-15 | 2000-03-20 | Compositions and methods for the treatment of immune related diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3902600A true AU3902600A (en) | 2001-04-17 |
Family
ID=22273632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU39026/00A Abandoned AU3902600A (en) | 1999-09-15 | 2000-03-20 | Compositions and methods for the treatment of immune related diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3902600A (en) |
WO (1) | WO2001019991A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003300395A1 (en) * | 2002-12-24 | 2004-07-22 | Amgen Inc. | Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
CN105288019A (en) * | 2015-12-03 | 2016-02-03 | 济南科纳信息科技有限公司 | Traditional Chinese medicine for treating lymphocytic thyroiditis |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6066322A (en) * | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
US5874230A (en) * | 1996-07-10 | 1999-02-23 | Tularik, Inc. | Assays using TRAF2-associated protein kinase polypeptides |
WO1998011138A1 (en) * | 1996-09-12 | 1998-03-19 | Human Genome Sciences, Inc. | Chemokine alpha-4 |
WO1998024908A1 (en) * | 1996-12-05 | 1998-06-11 | Human Genome Sciences, Inc. | Human chemokine beta-13 |
AU9395998A (en) * | 1997-09-17 | 1999-04-05 | Genentech Inc. | Compositions and methods for the treatment of immune related diseases |
NZ503343A (en) * | 1997-09-17 | 2002-09-27 | Genentech Inc | Secreted and transmembrane polypeptides and use to induce apoptosis of tumour cells |
ES2316175T3 (en) * | 1997-11-21 | 2009-04-01 | Genentech, Inc. | SPECIFIC ANTIGENS OF PLATQUETS AND THEIR PHARMACOLOGICAL USES. |
CA2343577A1 (en) * | 1998-09-16 | 2000-03-23 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU6498499A (en) * | 1998-09-17 | 2000-04-03 | Genentech Inc. | Compositions and methods for the treatment of immune related diseases |
KR100529270B1 (en) * | 1998-12-01 | 2005-11-21 | 제넨테크, 인크. | Promotion or Inhibition of Angiogenesis and Cardiovascularization |
-
2000
- 2000-03-20 WO PCT/US2000/007377 patent/WO2001019991A1/en active Application Filing
- 2000-03-20 AU AU39026/00A patent/AU3902600A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001019991A1 (en) | 2001-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7722600A (en) | Compositions and methods for the diagnosis and treatment of immune disorders | |
WO2003072035A8 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004041170A9 (en) | Compositions and methods for the treatment of immune related diseases | |
IL145470A0 (en) | Compositions for the treatment of immune diseases | |
AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
WO2004024097A9 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2495200A (en) | Compositions and methods for the treatment of tumor | |
AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
EP1572116A4 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2212299A (en) | Compositions and methods for the treatment of tumor | |
AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
KR100510795B1 (en) | Compositions and Methods for the Treatment of Tumor | |
AU4340700A (en) | Methods and compositions for use in the treatment of hyperlipidemia | |
AUPQ415899A0 (en) | Compositions for and methods of treatment of allergic diseases | |
AU5309600A (en) | Compositions and methods for the treatment and diagnosis of immune disorders | |
AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
AU4511201A (en) | Compositions and methods for the induction and treatment of retinal detachments | |
AU1953701A (en) | Methods and compositions for treatment of inflammatory disease | |
AU4228000A (en) | Methods and compositions for the treatment and prevention of lung disease | |
EP1472273A4 (en) | Compositions and methods for the treatment of immune related diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |